China
· Delayed Price · Currency is CNY Kangmei Pharmaceutical Statistics
Total Valuation
SHA:600518 has a market cap or net worth of CNY 26.76 billion. The enterprise value is 26.04 billion.
| Market Cap | 26.76B |
| Enterprise Value | 26.04B |
Important Dates
The next estimated earnings date is Thursday, August 21, 2025.
| Earnings Date | Aug 21, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
SHA:600518 has 13.86 billion shares outstanding. The number of shares has increased by 62.20% in one year.
| Current Share Class | 13.86B |
| Shares Outstanding | 13.86B |
| Shares Change (YoY) | +62.20% |
| Shares Change (QoQ) | -38.65% |
| Owned by Insiders (%) | 0.00% |
| Owned by Institutions (%) | 11.43% |
| Float | 10.02B |
Valuation Ratios
The trailing PE ratio is 2,784.85.
| PE Ratio | 2,784.85 |
| Forward PE | n/a |
| PS Ratio | 5.06 |
| PB Ratio | 3.71 |
| P/TBV Ratio | 4.01 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 2,710.69 |
| EV / Sales | 4.93 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -103.75 |
Financial Position
The company has a current ratio of 1.18, with a Debt / Equity ratio of 0.02.
| Current Ratio | 1.18 |
| Quick Ratio | 0.70 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.58 |
| Interest Coverage | -17.53 |
Financial Efficiency
Return on equity (ROE) is 0.17% and return on invested capital (ROIC) is -2.99%.
| Return on Equity (ROE) | 0.17% |
| Return on Assets (ROA) | -1.58% |
| Return on Invested Capital (ROIC) | -2.99% |
| Return on Capital Employed (ROCE) | -4.46% |
| Revenue Per Employee | 1.25M |
| Profits Per Employee | 2,270 |
| Employee Count | 4,233 |
| Asset Turnover | 0.38 |
| Inventory Turnover | 1.72 |
Taxes
In the past 12 months, SHA:600518 has paid 25.23 million in taxes.
| Income Tax | 25.23M |
| Effective Tax Rate | 66.98% |
Stock Price Statistics
The stock price has increased by +4.92% in the last 52 weeks. The beta is 0.72, so SHA:600518's price volatility has been lower than the market average.
| Beta (5Y) | 0.72 |
| 52-Week Price Change | +4.92% |
| 50-Day Moving Average | 1.98 |
| 200-Day Moving Average | 2.12 |
| Relative Strength Index (RSI) | 40.79 |
| Average Volume (20 Days) | 145,451,915 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:600518 had revenue of CNY 5.29 billion and earned 9.61 million in profits. Earnings per share was 0.00.
| Revenue | 5.29B |
| Gross Profit | 715.51M |
| Operating Income | -351.78M |
| Pretax Income | 37.67M |
| Net Income | 9.61M |
| EBITDA | -72.45M |
| EBIT | -351.78M |
| Earnings Per Share (EPS) | 0.00 |
Balance Sheet
The company has 894.22 million in cash and 146.65 million in debt, giving a net cash position of 747.57 million or 0.05 per share.
| Cash & Cash Equivalents | 894.22M |
| Total Debt | 146.65M |
| Net Cash | 747.57M |
| Net Cash Per Share | 0.05 |
| Equity (Book Value) | 7.22B |
| Book Value Per Share | 0.52 |
| Working Capital | 1.08B |
Cash Flow
In the last 12 months, operating cash flow was -196.46 million and capital expenditures -54.58 million, giving a free cash flow of -251.04 million.
| Operating Cash Flow | -196.46M |
| Capital Expenditures | -54.58M |
| Free Cash Flow | -251.04M |
| FCF Per Share | -0.02 |
Margins
Gross margin is 13.53%, with operating and profit margins of -6.65% and 0.18%.
| Gross Margin | 13.53% |
| Operating Margin | -6.65% |
| Pretax Margin | 0.71% |
| Profit Margin | 0.18% |
| EBITDA Margin | -1.37% |
| EBIT Margin | -6.65% |
| FCF Margin | n/a |
Dividends & Yields
SHA:600518 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 7.81% |
| Buyback Yield | -62.20% |
| Shareholder Yield | n/a |
| Earnings Yield | 0.04% |
| FCF Yield | -0.94% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on June 16, 2015. It was a forward split with a ratio of 2.
| Last Split Date | Jun 16, 2015 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
SHA:600518 has an Altman Z-Score of 0.57 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.57 |
| Piotroski F-Score | 2 |